Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives

Genetic editing technologies have emerged as a potential therapeutic tool in various biomedical fields owing to their applications against cancer, neurological diseases, diabetes, autoimmune disorder, muscular dystrophy, bacterial infections (AMR), and cardiovascular diseases. CRISPR is one such val...

Full description

Bibliographic Details
Main Authors: Rahul Bhattacharjee, Ankit Jana, Aditya Nandi, Adrija Sinha, Arkadyuti Bhattacharjee, Sagnik Mitra, Sulagna Kar, Abhijit Dey, Sushil Kumar Singh, Rajender S. Varma, Pritam Kumar Panda, Mrutyunjay Suar, Suresh K. Verma
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Materials & Design
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0264127522010383
_version_ 1798006948535205888
author Rahul Bhattacharjee
Ankit Jana
Aditya Nandi
Adrija Sinha
Arkadyuti Bhattacharjee
Sagnik Mitra
Sulagna Kar
Abhijit Dey
Sushil Kumar Singh
Rajender S. Varma
Pritam Kumar Panda
Mrutyunjay Suar
Suresh K. Verma
author_facet Rahul Bhattacharjee
Ankit Jana
Aditya Nandi
Adrija Sinha
Arkadyuti Bhattacharjee
Sagnik Mitra
Sulagna Kar
Abhijit Dey
Sushil Kumar Singh
Rajender S. Varma
Pritam Kumar Panda
Mrutyunjay Suar
Suresh K. Verma
author_sort Rahul Bhattacharjee
collection DOAJ
description Genetic editing technologies have emerged as a potential therapeutic tool in various biomedical fields owing to their applications against cancer, neurological diseases, diabetes, autoimmune disorder, muscular dystrophy, bacterial infections (AMR), and cardiovascular diseases. CRISPR is one such valuable genetic editing tool with extensive therapeutic appliances but with a major challenge in terms of delivery. Herein, we have strived to exploit a synergy of nanocarriers and CRISPR against the aforementioned diseases for their medical applications and explicated their clinical significance including the enhanced delivery via endosomal escape and environmental factors such as light, pH, and stimuli. In addition to highlighting the delivery strategies of nano-carriers for CRISPR and their characterization, we have expounded on the reliant factor of the CRISPR-Cas Complex.
first_indexed 2024-04-11T13:02:34Z
format Article
id doaj.art-429f7115849f45da982961a1ab1ca2af
institution Directory Open Access Journal
issn 0264-1275
language English
last_indexed 2024-04-11T13:02:34Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Materials & Design
spelling doaj.art-429f7115849f45da982961a1ab1ca2af2022-12-22T04:22:52ZengElsevierMaterials & Design0264-12752022-12-01224111415Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectivesRahul Bhattacharjee0Ankit Jana1Aditya Nandi2Adrija Sinha3Arkadyuti Bhattacharjee4Sagnik Mitra5Sulagna Kar6Abhijit Dey7Sushil Kumar Singh8Rajender S. Varma9Pritam Kumar Panda10Mrutyunjay Suar11Suresh K. Verma12KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, IndiaKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, IndiaKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, IndiaKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, IndiaKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, IndiaKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, IndiaKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, IndiaDepartment of Life Sciences, Presidency University, 86/1 College Street, Kolkata 700073, West Bengal, IndiaDBT-NECAB, Department of Agricultural Biotechnology, Assam Agriculture University, Jorhat 785013, Assam, IndiaRegional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic; Corresponding authors at: KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India (S.K. Verma).Condensed Matter Theory Group, Materials Theory Division, Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 20 Uppsala, Sweden; Corresponding authors at: KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India (S.K. Verma).KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India; Corresponding authors at: KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India (S.K. Verma).KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India; Condensed Matter Theory Group, Materials Theory Division, Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 20 Uppsala, Sweden; Corresponding authors at: KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India (S.K. Verma).Genetic editing technologies have emerged as a potential therapeutic tool in various biomedical fields owing to their applications against cancer, neurological diseases, diabetes, autoimmune disorder, muscular dystrophy, bacterial infections (AMR), and cardiovascular diseases. CRISPR is one such valuable genetic editing tool with extensive therapeutic appliances but with a major challenge in terms of delivery. Herein, we have strived to exploit a synergy of nanocarriers and CRISPR against the aforementioned diseases for their medical applications and explicated their clinical significance including the enhanced delivery via endosomal escape and environmental factors such as light, pH, and stimuli. In addition to highlighting the delivery strategies of nano-carriers for CRISPR and their characterization, we have expounded on the reliant factor of the CRISPR-Cas Complex.http://www.sciencedirect.com/science/article/pii/S0264127522010383NanocarriersCRISPR-Cas complexNon-viral vectorGenome editing
spellingShingle Rahul Bhattacharjee
Ankit Jana
Aditya Nandi
Adrija Sinha
Arkadyuti Bhattacharjee
Sagnik Mitra
Sulagna Kar
Abhijit Dey
Sushil Kumar Singh
Rajender S. Varma
Pritam Kumar Panda
Mrutyunjay Suar
Suresh K. Verma
Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
Materials & Design
Nanocarriers
CRISPR-Cas complex
Non-viral vector
Genome editing
title Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
title_full Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
title_fullStr Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
title_full_unstemmed Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
title_short Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
title_sort synergy of nanocarriers with crispr cas9 in an emerging technology platform for biomedical appliances current insights and perspectives
topic Nanocarriers
CRISPR-Cas complex
Non-viral vector
Genome editing
url http://www.sciencedirect.com/science/article/pii/S0264127522010383
work_keys_str_mv AT rahulbhattacharjee synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT ankitjana synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT adityanandi synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT adrijasinha synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT arkadyutibhattacharjee synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT sagnikmitra synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT sulagnakar synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT abhijitdey synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT sushilkumarsingh synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT rajendersvarma synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT pritamkumarpanda synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT mrutyunjaysuar synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives
AT sureshkverma synergyofnanocarrierswithcrisprcas9inanemergingtechnologyplatformforbiomedicalappliancescurrentinsightsandperspectives